Macro strategist Jordi Visser delivered a striking observation on a recent episode of The Pomp Podcast with Anthony Pompliano ...
Eli Lilly and Company (NYSE:LLY) is one of the top long-term stocks to buy. On May 25, Eli Lilly and Company (NYSE:LLY) ...
Eli Lilly and Company (NYSE:LLY) is included among the 10 Safe Stocks to Buy for the Long Term in 2026. On May 26, BofA ...
Eli Lilly (LLY) just did something worth paying attention to. With CVS Caremark announcing coverage of both Zepbound and ...
StockStory.org on MSN
Why Eli Lilly (LLY) stock is trading up today
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.4% in the afternoon session after CVS ...
Eli Lilly's robust guidance despite higher costs on acquisitions and underwhelming performance by Foundayo indicates its ...
Zacks Investment Research on MSN
LLY stock gains 4% to all-time high: Is obesity access the catalyst?
Eli Lilly LLY shares climbed 4.1% on Thursday to a record high of $1,126.80, lifting the drugmaker’s market capitalization to ...
Eli Lilly & Company (NYSE:LLY) ranks among the best stocks for a couch potato portfolio. Following worries over hepatic ...
Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...
Eli Lilly (NYSE:LLY | LLY Price Prediction) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5% year ...
Eli Lilly stock (NYSE: LLY) should be on your radar. Here’s why – it is presently trading within the support range ($688 – $761), price points from which it has previously bounced significantly. Over ...
Eli Lilly continues strong execution, exceeding revenue expectations and expanding its pipeline with strategic, low-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results